Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 42, Issue 11, Pages 1913-1920
Publisher
Springer Science and Business Media LLC
Online
2021-10-12
DOI
10.1038/s41401-021-00770-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study
- (2020) Ola Olén et al. LANCET
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
- (2020) Kristina E Rudd et al. LANCET
- Immunotherapy in sepsis - brake or accelerate?
- (2020) Folkert Steinhagen et al. PHARMACOLOGY & THERAPEUTICS
- Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation
- (2020) Wenmin Deng et al. FREE RADICAL BIOLOGY AND MEDICINE
- SARS-CoV-2 and viral sepsis: observations and hypotheses
- (2020) Hui Li et al. LANCET
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Immunotherapies for COVID-19: lessons learned from sepsis
- (2020) Kenneth E Remy et al. Lancet Respiratory Medicine
- Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases
- (2020) Yuge Zhao et al. Acta Pharmaceutica Sinica B
- Cardiometabolic Traits, Sepsis and Severe COVID-19: A Mendelian Randomization Investigation
- (2020) Mark J. Ponsford et al. CIRCULATION
- Ulcerative colitis
- (2020) Taku Kobayashi et al. Nature Reviews Disease Primers
- Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand
- (2020) Ahmed O. Elzoghby et al. BIOMATERIALS
- LRP1 receptor-mediated immunosuppression of α-MMC on monocytes
- (2019) Nianhua Deng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
- (2019) Yi Rang Na et al. Nature Reviews Gastroenterology & Hepatology
- The Epidemiology of Sepsis in Chinese ICUs
- (2019) Jianfeng Xie et al. CRITICAL CARE MEDICINE
- Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down‐regulating the nuclear factor‐kappa B signaling
- (2019) Tian Hua Ren et al. Journal of Digestive Diseases
- Role of Lactoferrin in Neonates and Infants: An Update
- (2018) Alberto Dall'Agnola et al. AMERICAN JOURNAL OF PERINATOLOGY
- The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness
- (2018) Kevin C. Ma et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mechanisms and treatment of organ failure in sepsis
- (2018) Christophe Lelubre et al. Nature Reviews Nephrology
- Epidemiology and Immune Pathogenesis of Viral Sepsis
- (2018) Gu-Lung Lin et al. Frontiers in Immunology
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Lactoferrin in a Context of Inflammation-Induced Pathology
- (2017) Marian L. Kruzel et al. Frontiers in Immunology
- GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
- (2016) Lorenzo Sborgi et al. EMBO JOURNAL
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- Sepsis: pathophysiology and clinical management
- (2016) Jeffrey E Gotts et al. BMJ-British Medical Journal
- Sepsis: pathophysiology and clinical management
- (2016) Jeffrey E Gotts et al. BMJ-British Medical Journal
- Sepsis and septic shock
- (2016) Richard S. Hotchkiss et al. Nature Reviews Disease Primers
- Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
- (2015) Wan-ting He et al. CELL RESEARCH
- Sepsis: a roadmap for future research
- (2015) Jonathan Cohen et al. LANCET INFECTIOUS DISEASES
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- Sepsis: Current Dogma and New Perspectives
- (2014) Clifford S. Deutschman et al. IMMUNITY
- Smart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and Disulfiram
- (2013) Xiaopin Duan et al. ACS Nano
- Lactoferrin moderates LPS-induced hypotensive response and gut injury in rats
- (2012) Marie-Francoise Doursout et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Review article: remission rates achievable by current therapies for inflammatory bowel disease
- (2011) L. Peyrin-Biroulet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects
- (2011) Maria Elisa Drago-Serrano et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Animal models of sepsis and its complications
- (2008) Mitchell P. Fink KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started